Gene · 833
Papers4,113
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 4,113
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CAR-NK Cells Targeting HER1 (EGFR) Show Efficient Anti-Tumor Activity against Head and Neck Squamous Cell Carcinoma (HNSCC). | Cancers (Basel) | 2023 | 37370779 | PubTator, text mining | PubMed |
| CD28 and 41BB Costimulatory Domains Alone or in Combination Differentially Influence Cell Surface Dynamics and Organization of Chimeric Antigen Receptors and Early Activation of CAR T Cells. | Cancers (Basel) | 2023 | 37370693 | PubTator, text mining | PubMed |
| The Role of Immunotherapy in the Treatment of Rare Central Nervous System Tumors. | Curr Oncol | 2023 | 37366884 | PubTator, text mining | PubMed |
| Bispecific PSMA antibodies and CAR-T in metastatic castration-resistant prostate cancer. | Ther Adv Urol | 2023 | 37359737 | PubTator, text mining | PubMed |
| Self-delivery of TIGIT-blocking scFv enhances CAR-T immunotherapy in solid tumors. | Front Immunol | 2023 | 37359558 | PubTator, text mining | PubMed |
| DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy. | Front Immunol | 2023 | 37359555 | PubTator, text mining | PubMed |
| Rapid generation of CD19 CAR-T cells by minicircle DNA enables anti-tumor activity and prevents fatal CAR-B leukemia. | Cancer Lett | 2023 | 37354981 | PubTator, text mining | PubMed |
| Organ-specific heterogeneity in tumor-infiltrating immune cells and cancer antigen expression in primary and autologous metastatic lung adenocarcinoma. | J Immunother Cancer | 2023 | 37349126 | PubTator, text mining | PubMed |
| Evaluation of the Elements of Short Hairpin RNAs in Developing shRNA-Containing CAR T Cells. | Cancers (Basel) | 2023 | 37345185 | PubTator, text mining | PubMed |
| The MAL Family of Proteins: Normal Function, Expression in Cancer, and Potential Use as Cancer Biomarkers. | Cancers (Basel) | 2023 | 37345137 | PubTator, text mining | PubMed |
| Anti-Tumor Strategies by Harnessing the Phagocytosis of Macrophages. | Cancers (Basel) | 2023 | 37345054 | PubTator, text mining | PubMed |
| The Black Hole: CAR T Cell Therapy in AML. | Cancers (Basel) | 2023 | 37345050 | PubTator, text mining | PubMed |
| Cell metabolism-based optimization strategy of CAR-T cell function in cancer therapy. | Front Immunol | 2023 | 37342333 | PubTator, text mining | PubMed |
| Chimeric antigen receptor T cells targeting FcRH5 provide robust tumour-specific responses in murine xenograft models of multiple myeloma. | Nat Commun | 2023 | 37339964 | PubTator, text mining | PubMed |
| Harnessing αβ T cell receptor mechanobiology to achieve the promise of immuno-oncology. | Proc Natl Acad Sci U S A | 2023 | 37339184 | PubTator, text mining | PubMed |
| Direct In Vivo Activation of T Cells with Nanosized Immunofilaments Inhibits Tumor Growth and Metastasis. | ACS Nano | 2023 | 37338806 | PubTator, text mining | PubMed |
| Chimeric antigen receptor T-cells: Properties, production, and quality control. | Int J Lab Hematol | 2023 | 37337970 | PubTator, text mining | PubMed |
| CAR T Cell Therapy: Remedies of Current Challenges in Design, Injection, Infiltration and Working. | Drug Des Devel Ther | 2023 | 37337518 | PubTator, text mining | PubMed |
| Exploration of T cell immune responses by expression of a dominant-negative SHP1 and SHP2. | Front Immunol | 2023 | 37334382 | PubTator, text mining | PubMed |
| T cells in health and disease. | Signal Transduct Target Ther | 2023 | 37332039 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/833/papers?page=28